| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |